News
AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or “the Company”), a clinical-stage biopharmaceutical company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback